GlaxoSmithKline to supply HHS with 60,000 doses of raxibacumab, anthrax antitoxin
The US Department of Health and Human Services (HHS) has announced today the nation’s supply of anthrax antitoxin will be maintained until 2018 under Project BioShield contracts issued by the U.S. Department of More...
Senator Claire McCaskill questions Richard Danzig’s influence in the government’s procurement of the anthrax anti-toxin, raxibacumab
Senator Claire McCaskill (D-MO) is calling on the Inspectors General for the Department of Defense and the Department of Homeland Security to investigate contracts awarded to former Navy Secretary Richard Danzig, More...
Inhalation anthrax treatment, raxibacumab, gets FDA approval
Anthrax Image/CIA The U.S. Food and Drug Administration today approved GlaxoSmithKline’s raxibacumab injection to treat inhalation anthrax, a lethal form of the infectious disease caused by breathing in the More...